Efficacy and safety of levetiracetam versus valproate in patients with established status epilepticus: A systematic review and meta-analysis.

Shixin Wang,Xin Wu,Tao Xue,Zhaoming Song,Xin Tan,Xiaoou Sun,Zhong Wang

Heliyon（2023）

引用 0|浏览8

暂无评分

摘要

Levetiracetam (LEV) was not superior to valproate (VPA) in terms of efficacy or safety outcomes. In addition, children (<18 years) and adults (>18 years) might have similar responses to LEV and VPA. Additional RCTs are required to verify our results.

查看译文

关键词

Established status epilepticus,Levetiracetam,Meta-analysis,Valproate

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要